Charles Sermon is General Counsel of Mereo Biopharma Group plc. Currently has a direct ownership of 219,061 shares of MREO, which is worth approximately $589,274. The most recent transaction as insider was on Sep 13, 2024, when has been sold 20,946 shares (American Depositary Shares representing Ordinary Shares) at a price of $4.22 per share, resulting in proceeds of $88,392. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 219K
0% 3M change
n/a 12M change
Total Value Held $589,274

Charles Sermon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 13 2024
SELL
Open market or private sale
$88,392 $4.22 p/Share
20,946 Reduced 8.73%
219,061 American Depositary Sh...
Sep 12 2024
SELL
Open market or private sale
$44,610 $4.47 p/Share
9,980 Reduced 3.99%
240,007 American Depositary Sh...
Sep 11 2024
BUY
Exercise of conversion of derivative security
-
65,600 Added 20.79%
249,987 American Depositary Sh...
Jun 26 2024
SELL
Open market or private sale
$109,113 $3.39 p/Share
32,187 Reduced 14.86%
184,387 American Depositary Sh...
Jun 25 2024
SELL
Open market or private sale
$52,405 $3.69 p/Share
14,202 Reduced 6.15%
216,574 American Depositary Sh...
Jun 21 2024
BUY
Exercise of conversion of derivative security
-
98,400 Added 29.89%
230,776 American Depositary Sh...
CS

Charles Sermon

General Counsel
London, X0

Track Institutional and Insider Activities on MREO

Follow Mereo Biopharma Group plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MREO shares.

Notify only if
Any

Insider Trading

Get notified when an Mereo Biopharma Group PLC insider buys or sells MREO shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Mereo Biopharma Group plc

Track Activities on MREO